1. Home
  2. INLF vs BJDX Comparison

INLF vs BJDX Comparison

Compare INLF & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INLF

INLIF LIMITED

HOLD

Current Price

$0.11

Market Cap

2.2M

Sector

Industrials

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$3.86

Market Cap

1.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLF
BJDX
Founded
2016
2015
Country
China
United States
Employees
156
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
INLF
BJDX
Price
$0.11
$3.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.9M
2.4M
Earning Date
03-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
86.65
EPS
N/A
N/A
Revenue
N/A
$249,040.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.63
52 Week High
$5.20
$7.00

Technical Indicators

Market Signals
Indicator
INLF
BJDX
Relative Strength Index (RSI) 20.71 54.49
Support Level N/A $1.46
Resistance Level $0.66 $4.01
Average True Range (ATR) 0.72 0.89
MACD -0.49 -0.08
Stochastic Oscillator 0.16 7.87

Price Performance

Historical Comparison
INLF
BJDX

About INLF INLIF LIMITED

INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

Share on Social Networks: